Gliadel

(carmustine)
GLIADEL Wafer 7.7 MG Intracavitary Drug Implant
NO BLACK BOX WARNING

Dosage & administration

biomarker testing

Gliadel clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Gliadel prescribing information

prior authorization

Gliadel prior authorization resources

OTHER
Complete Letter of Medical Necessity

OTHER
Coverage Authorization Appeals
Learn More

Reimbursement help (FRM)

OTHER
Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Gliadel financial assistance options

Co-pay savings program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

OTHER
Arbor Patient Assistance Program
Learn More

patient education

Gliadel patient education

Getting started on Gliadel

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

BRAND PAGE
About Gliadel
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Gliadel FAQs

How is the dosage of Gliadel?Gliadel is available in 1 dosages, including 7.7 mg Drug Implant
What does Gliadel treat?Gliadel treats Brain Neoplasms, Carcinoma, Colonic Neoplasms, Ependymoma, Glioblastoma, Hodgkin Disease, Lung Neoplasms, Non-Hodgkin Lymphoma, Medulloblastoma, Melanoma and Multiple Myeloma
What is Gliadel made of?Gliadel contains carmustine which is a Alkylating Drug
How Is Gliadel Administered?Gliadel is administered as a Implant
What Are The Gliadel Mechanism Of Action?Gliadel mechanism of action is Alkylating Activity
FAQ Data Source